Evidence-based beta blocker use associated with lower heart failure readmission and mortality, but not all-cause readmission, among Medicare beneficiaries hospitalized for heart failure with reduced ejection fraction

The beta blockers carvedilol, bisoprolol, and sustained-release metoprolol succinate reduce readmissions and mortality among patients with heart failure with reduced ejection fraction (HFrEF), based upon clinical trial and registry studies. Results from these studies may not generalize to the typica...

Descripción completa

Detalles Bibliográficos
Autores principales: Loop, Matthew Shane, Van Dyke, Melissa K., Chen, Ligong, Brown, Todd M., Durant, Raegan W., Safford, Monika M., Levitan, Emily B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347167/
https://www.ncbi.nlm.nih.gov/pubmed/32645049
http://dx.doi.org/10.1371/journal.pone.0233161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347167/
https://www.ncbi.nlm.nih.gov/pubmed/32645049
http://dx.doi.org/10.1371/journal.pone.0233161

Ejemplares similares